Education
About Us
Working with TipRanks
Follow Us
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
RESEARCH TOOLSreports
WST Stock Chart & Stats
Day’s Range― - ―
52-Week Range$187.43 - $352.33
Previous CloseN/A
Volume102.64K
Average Volume (3M)761.19K
Market Cap
$17.58B
Enterprise Value$15.66B
Total Cash (Recent Filing)$509.70M
Total Debt (Recent Filing)$303.30M
Price to Earnings (P/E)37.0
Beta0.87
Next Earnings
Oct 23, 2025EPS Estimate
1.68Next Dividend Ex-Date
Nov 12, 2025Dividend Yield0.34%
Share Statistics
EPS (TTM)1.84
Shares Outstanding71,907,326
10 Day Avg. Volume506,508
30 Day Avg. Volume761,186
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.89
Enterprise Value/Revenue5.29
Enterprise Value/Gross Profit14.98
Enterprise Value/Ebitda20.60
Forecast
1Y Price Target
$312.50Price Target Upside27.05% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Bulls Say, Bears Say
Bulls Say
Financial PerformanceWest Pharmaceutical Services reported revenue of $766.5 million, surpassing both internal and consensus estimates.
Guidance And ForecastsGuidance for 2025 was raised with expectations of increased total reported revenue and organic growth.
Bears Say
Operational ChallengesThe company is currently facing several headwinds, including industry-specific challenges like tariffs and company-specific issues like the roll-off of contracts.
Product ChallengesThe recent SmartDose launch has resulted in negative gross margins, which management must address to achieve long-term revenue growth and margin targets.
Profit MarginsOperating profit margin contracted to 15.3% from 17.7%, impacted by restructuring charges and a shift in product mix away from higher-margin components.
West Pharmaceutical Services News
WST FAQ
What was West Pharmaceutical Services, Inc.’s price range in the past 12 months?
West Pharmaceutical Services, Inc. lowest stock price was $187.43 and its highest was $352.33 in the past 12 months.
What is West Pharmaceutical Services, Inc.’s market cap?
West Pharmaceutical Services, Inc.’s market cap is $17.58B.
When is West Pharmaceutical Services, Inc.’s upcoming earnings report date?
West Pharmaceutical Services, Inc.’s upcoming earnings report date is Oct 23, 2025 which is in 56 days.
How were West Pharmaceutical Services, Inc.’s earnings last quarter?
West Pharmaceutical Services, Inc. released its earnings results on Jul 24, 2025. The company reported $1.84 earnings per share for the quarter, beating the consensus estimate of $1.509 by $0.331.
Is West Pharmaceutical Services, Inc. overvalued?
According to Wall Street analysts West Pharmaceutical Services, Inc.’s price is currently Undervalued.
Does West Pharmaceutical Services, Inc. pay dividends?
West Pharmaceutical Services, Inc. pays a Quarterly dividend of $0.22 which represents an annual dividend yield of 0.34%. See more information on West Pharmaceutical Services, Inc. dividends here
What is West Pharmaceutical Services, Inc.’s EPS estimate?
West Pharmaceutical Services, Inc.’s EPS estimate is 1.68.
How many shares outstanding does West Pharmaceutical Services, Inc. have?
West Pharmaceutical Services, Inc. has 71,907,326 shares outstanding.
What happened to West Pharmaceutical Services, Inc.’s price movement after its last earnings report?
West Pharmaceutical Services, Inc. reported an EPS of $1.84 in its last earnings report, beating expectations of $1.509. Following the earnings report the stock price went up 22.785%.
Which hedge fund is a major shareholder of West Pharmaceutical Services, Inc.?
Currently, no hedge funds are holding shares in WST
West Pharmaceutical Services Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$312.50 (27.05% Upside)
$312.50 (27.05% Upside)
Blogger Sentiment
Bullish
WST Sentiment 71%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 1.0M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.6%
Last 30 Days ▲ 9.8%
Last 30 Days ▲ 9.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.18%
12-Months-Change
Fundamentals
Return on Equity
17.72%
Trailing 12-Months
Asset Growth
13.28%
Trailing 12-Months
Company Description
West Pharmaceutical Services, Inc.
West Pharmaceutical Services (WST) is a global leader in the design and manufacturing of innovative solutions for injectable drug delivery. The company operates primarily in the pharmaceutical and biotechnology sectors, providing a comprehensive range of products including drug delivery systems, containment solutions, and related services. West's offerings encompass a variety of components such as stoppers, syringes, and vial systems, which are essential for the safe and effective administration of injectable medications. With a focus on enhancing patient safety and improving drug efficacy, West serves a diverse clientele that includes major pharmaceutical companies and biopharmaceutical firms worldwide.
WST Company Deck
WST Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a positive sentiment overall, with strong revenue growth, improved financial metrics, and upward revisions to guidance. However, there were ongoing challenges with destocking in the generics market, plant constraints in Europe, and uncertainties around tariff impacts.View all WST earnings summariesWST Revenue Breakdown
80.69% Proprietary Products
19.31% Contract-Manufactured Products
0.00% Intersegment sales elimination
WST Stock 12 Month Forecast
Average Price Target
$312.50
▲(27.05% Upside)
Technical Analysis
Ownership Overview
0.57% Insiders
27.58% Mutual Funds
24.35% Other Institutional Investors
17.81% Public Companies and
Individual Investors